Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | PPARG | P37231 | 8/20 | 0.42 |
| ▸ | PPARA | Q07869 | 6/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3678882 | 1.00 | RAB9A (0.47) | RAB9ANPC1PPARGPPARAMAOB | |
| SCHEMBL25344075 | 0.91 | NPC1 (0.50) | RAB9ANPC1PPARGPPARAMAOB | |
| SCHEMBL19566191 | 0.83 | NPC1 (0.48) | RAB9ANPC1PPARGPPARAMAOB | |
| SCHEMBL3684410 | 0.83 | RAB9A (0.41) | RAB9ANPC1PPARGPPARAMAOB | |
| SCHEMBL3690487 | 0.83 | DPP4 (0.38) | RAB9ANPC1PPARGPPARAMEN1 | |
| SCHEMBL3690484 | 0.83 | DPP4 (0.38) | RAB9ANPC1PPARGPPARAMEN1 | |
| SCHEMBL28483106 | 0.82 | RAB9A (0.51) | RAB9ANPC1PPARGPPARAMAOB | |
| SCHEMBL26317 | 0.81 | NPC1 (0.53) | RAB9ANPC1PPARGPPARAMAOB | |
| SCHEMBL26318 | 0.81 | NPC1 (0.53) | RAB9ANPC1PPARGPPARAMAOB | |
| SCHEMBL18243 | 0.80 | NPC1 (0.49) | RAB9ANPC1PPARGPPARAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9480250-B2 | Production of solid solutions of pesticides by short-term superheating and rapid drying | BASF SE (DE) | 2016-11-01 | — | — | US | disclosed |
| US-20100062940-A1 | Production of Solid Solutions of Pesticides by Short-Term Superheating and Rapid Drying | BASF SE (DE) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100062940-A1 | Production of Solid Solutions of Pesticides by Short-Term Superheating and Rapid Drying | ACHE, CS, STOM | RAB9A 3202/4885NPC1 3441/4885PPARG 894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.